Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 952-692-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://www.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 1992-08-05, 1992-09-07
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Guideline study with acceptable restrictions (2-aminoanthracene was the only positive control compound used for reactions performed in the presence of metabolic activation).
- Justification for type of information:
- Thiobis Propanoic Acid Derivatives
The category covers thiiodipropionates that are symmetrically esterified by two linear aliphatic groups ranging in size from C10 to C24
The justification for the category is based on the expectation that the close structural similarity should result in properties that are either similar or follow a pattern that correlates with changes in the molecular weights of the compounds. The category members are high-molecular weight dithiopropionate esters that differ only in the chain length of the dialkyl ester functions and are expected to follow a regular pattern for all endpoints.
Based on the structures and molecularweights of the category members, as well as available data on category members, The predictive methods and extrapolation and interpolation of data within the category are acceptable. Data provided by other sources also demonstrate that these compounds generally have mammalian toxicities that are similar (e.g., acute oral LD 50, acute irritation thresholds, and genotoxicities) or follow a pattern that parallels changes in molecular weight (e.g., repeated-dose NOAEL).
The category is adequately supported based on chemical structure and available data.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- (2-aminoanthracene was used as only positive control with metabolic activation.)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: UKEMS
- Deviations:
- not applicable
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Didodecyl 3,3'-thiodipropionate
- EC Number:
- 204-614-1
- EC Name:
- Didodecyl 3,3'-thiodipropionate
- Cas Number:
- 123-28-4
- Molecular formula:
- C30H58O4S
- IUPAC Name:
- didodecyl 3,3'-sulfanediyldipropanoate
- Details on test material:
- - Name of test material (as cited in study report): Dilauryl Thiodipropionate
- Physical state: white powder
- Purity test date: 1992-06-01, 1992-06-11
- Lot/batch No.: 05/92
- Storage condition of test material: In the dark at room temperature
Constituent 1
Method
- Target gene:
- his operon
Species / strain
- Species / strain / cell type:
- S. typhimurium, other: TA98, TA100, TA1535, TA1537, and TA102
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254.
- Test concentrations with justification for top dose:
- 1.6, 8, 40, 200, and 1000 µg/plate (experiment 1) and 62.5, 125, 250, 500, and 1000 µg/plate (experiment 2)
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- strain TA98
Migrated to IUCLID6: 50.0 µg/plate in DMSO
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- sodium azide
- Remarks:
- strains TA100 and TA1535
Migrated to IUCLID6: 2.0 µg/plate in water
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- 9-aminoacridine
- Remarks:
- strain TA1537
Migrated to IUCLID6: 50.0 µg/plate in DMSO
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- other: Glutaraldehyde (25.0 µg/plate in water)
- Remarks:
- strain TA102
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- with metabolic activation
- Positive control substance:
- other: 2-aminoanthracene 5.0 µg/plate in DMSO
- Remarks:
- at least applied in 1 strain
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation, experiment 1) and preincubation (with metabolic activation, experiment 2)
DURATION
- Preincubation period: 1 hours at 37 °C in nutrient broth (experiment 2)
- Exposure duration: 72 h at 37 °C (for both: in agar (plate incorporation) and preincubation test)
NUMBER OF REPLICATIONS: triplicate
DETERMINATION OF CYTOTOXICITY
- Method: The background lawn was inspected for signs of toxicity. - Evaluation criteria:
- The assay was considered valid if the following criteria were met:
i) the mean negative control counts fell within the normal range
ii) the positive control chemicals induced clear increases in revertant numbers confirming discrimination between different strains, and an active S-9 preparation
iii) no more than 5% of the plates were lost through contamination or some other unforeseen event.
A test compound was considered to be mutagenic if:
i) the assay was valid
ii) Dunnett's test gave a significant response (p <0.01), and the data set showed a significant dose-correlation
iii) the positive responses described in (ii) were reproducible - Statistics:
- For evaluation of test chemical and positive control data, the m-statistic was first calculated to check that the data were Poisson-distributed. Then, Dunnett's test was used to compare the counts of each dose with the control. The presence or otherwise of a dose response was then checked by linear regression analysis.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium, other: TA98, TA100, TA1535, TA1537, and TA102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium, other: TA98, TA100, TA1535, TA1537, and TA102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- presumably as the result of the increased exposure of the bacteria to the test agent due to the pre-incubation step.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Yes, at 1000 µg/plate (experiment 1) and at 500 and 1000 µg/plate (experiment 2)
RANGE-FINDING/SCREENING STUDIES: Strain TA100 at 8, 40, 200, 1000, and 5000 µg/plate. No evidence of toxicity. Heavy precipitation of test agent was observed at concentrations of both 1000 and 5000 µg/plate.
COMPARISON WITH HISTORICAL CONTROL DATA: Comparable - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'. Remarks: (experiment1)
Any other information on results incl. tables
Table 1: Revertants in S. typhimurium treated with the test substance, with and without metabolic activation (experiment 1):
Dose (µg/plate) |
TA98 |
TA100 |
TA1535 |
TA1537 |
TA 102 |
|||||
|
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
0 |
22.2±5.7 |
17.2±6.1 |
115.2±6.4 |
124±3.2 |
21.8±2.9 |
26.6±4.3 |
17.8±2.1 |
13±3.5 |
232.6±21.1 |
305.4±39.5 |
1.6 |
27.7±5.1 |
24±7 |
105.7±6.7 |
119±29.5 |
26±1 |
29±1 |
15±2.6 |
10.3±3.1 |
298±50.7 |
362.3±7.8 |
8 |
29.7±5.9 |
21.3±7.4 |
95.3±9.5 |
113.7±9.1 |
23.7±10.4 |
18.7±7.6 |
14.3±4.6 |
9±2.6 |
265.3±11.7 |
317.3±33.6 |
40 |
25.3±6.7 |
21±6.1 |
113±2 |
124±23.8 |
17.7±2.5 |
23.7±1.2 |
16±5.3 |
11.7±3.5 |
267.7±39.7 |
333±28.6 |
200 |
29.0±2.6 |
22.7±8.4 |
108.7±11.9 |
99.3±24 |
21.7±1.2 |
28±4.4 |
15±1 |
11.3±3.5 |
283.3±26.5 |
316.7±15.3 |
1000 |
21.0±3.0 |
16.7±4.7 |
123.3±9.2 |
91±11 |
21.7±3.8 |
24±2.6 |
8.7±3.5 |
9.7±4 |
276±17.4 |
292±52.3 |
2-NF |
1645.3±111.9 |
- |
- |
- |
- |
- |
- |
- |
- |
± |
NaN3 |
- |
- |
810.3 ±57.4 |
- |
463±57.7 |
- |
- |
- |
- |
- |
AAC |
- |
- |
- |
- |
- |
- |
425.7±9.1 |
- |
- |
- |
AAN |
- |
1367.3±147 |
- |
1800.3±249.7 |
- |
195.7±4 |
- |
- |
- |
- |
GLU |
- |
- |
- |
- |
- |
- |
- |
- |
477.7±45.8 |
- |
(Mean ± SD)
2-NF: 2-nitrofluorene;
NaN3: sodium azide
GLU: glutaraldehyde
AAC: 9-aminoacridine
AAN: aminoanthracene
Table 2: Revertants in S. typhimurium, treated with the test substance, with and without metabolic activation (experiment 2):
Dose (µg/plate) |
TA98 |
TA100 |
TA1535 |
TA1537 |
TA 102 |
|
|
|
|||||
|
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|
|
|
0 |
29.4±5.0 |
28±4.5 |
111.6±12.7 |
103.6±10.8 |
22.2±2.8 |
21±1.6 |
15.4±3.8 |
13±2.2 |
319.2±48.9 |
357±19.4 |
|
|
|
62.5 |
34.7±1.2 |
21±1.7 |
109±13.5 |
83.7±5.1 |
21.3±1.2 |
19.7±3.2 |
19.3±2.5 |
18.3±0.6 |
271±43.4 |
316±16.9 |
|
|
|
125 |
36.7±7 |
28.7±6.1 |
113±10.5 |
87.3±10 |
16.3±3.5 |
11.3±4 |
16±0 |
13.7±2.1 |
222.3±11.9 |
311.3±13.4 |
|
|
|
250 |
36.3±5.5 |
34.3±1.2 |
102.7±3.1 |
90±28.3 |
21.3±5.7 |
22.3±3.1 |
17±2 |
14.3±3.1 |
237.3±27.6 |
351.3±11.4 |
|
|
|
500 |
19.3±9 |
24±4.6 |
90.3±1.5 |
70.7±2.1 |
15±5 |
21.3±3.8 |
15.3±2.1 |
16.3±4.5 |
292.3±29.8 |
162.7±11 |
|
|
|
1000 |
25.3±11.0 |
18.7±2.5 |
101±13.9 |
75.3±3.8 |
16.3±2.5 |
21±2.4 |
14.3±6.1 |
10.3±1.2 |
232.7±17.7 |
190.7±11 |
|
|
|
2-NF |
1644±509.6 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|
|
NaN3 |
- |
- |
773.3 ±75.1 |
- |
479±49.4 |
- |
- |
- |
- |
- |
|
|
|
AAC |
- |
- |
- |
- |
- |
- |
643.3±227.7 |
- |
- |
- |
|
|
|
AAN |
- |
2213.7±125.1 |
- |
1451.7±38.1 |
- |
- |
- |
- |
- |
- |
|
|
|
GLU |
- |
- |
- |
- |
- |
- |
- |
- |
715.3±89.4 |
- |
|
|
|
(Mean ± SD)
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with and without metabolic acitvation
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)